SCHEMBL30922714

SCHEMBL30922714

CC(C)(C)[Si](C)(C)OC[C@H]1C[C@H]1c1c(Cl)cc2c(cnn2[C@H]2CCCCO2)c1Br

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33
▸ RXRG P48443 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30922930 0.90 CYP4F2 (0.33) RXRARXRBRXRG
SCHEMBL31642909 0.85 KRAS (0.33) RXRARXRBRXRG
SCHEMBL31642647 0.85 KRAS (0.33) RXRARXRBRXRG
SCHEMBL31642702 0.84 RXRA (0.41) RXRARXRBRXRG
SCHEMBL30922619 0.84 RXRA (0.41) RXRARXRBRXRG
SCHEMBL31642625 0.84 RXRA (0.37) RXRARXRBRXRG
SCHEMBL31642584 0.84 RXRA (0.37) RXRARXRBRXRG
SCHEMBL24535801 0.81 RXRA (0.37) RXRARXRBRXRG
SCHEMBL31127844 0.81 RXRA (0.37) RXRARXRBRXRG
SCHEMBL31127821 0.81 RXRA (0.37) RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598921-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE Amgen Inc. (US) 2025-08-13 — — EP disclosed
WO-2024107686-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2024-05-23 — — WO disclosed
Send feedback